Inteview: Polpharma Biologics – The Polish Biosimilar Powerhouse

“Other companies come to us and want CDMO work in the biosimilar space because we know what we’re doing, but our goal is not to become 100% biosimilars. Our goal is to become a leading biologics manufacturer and biosimilars are a part of what we do,” said our Vice President of Strategy, Programs and Portfolio – Alexandra Moulson in an interview with The Center for Biosimilars®.

Read the full interview and find out more about Polpharma Biologics CDMO services, forward expansion and whether COVID-19 had an impact on the company in recent months.

Alexandra Moulson,
Vice President of Strategy, Programs and Portfolio at Polpharma Biologics